These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
661 related items for PubMed ID: 30269271
1. Ultrasonographic Nonalcoholic Fatty Pancreas Is Associated with Advanced Fibrosis in NAFLD: A Retrospective Analysis. Rosenblatt R, Mehta A, Snell D, Hissong E, Kierans AS, Kumar S. Dig Dis Sci; 2019 Jan; 64(1):262-268. PubMed ID: 30269271 [Abstract] [Full Text] [Related]
7. MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease. Costa-Silva L, Ferolla SM, Lima AS, Vidigal PVT, Ferrari TCA. Eur J Radiol; 2018 Jan; 98():82-89. PubMed ID: 29279175 [Abstract] [Full Text] [Related]
10. The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease. Malik R, Chang M, Bhaskar K, Nasser I, Curry M, Schuppan D, Byrnes V, Afdhal N. J Gastroenterol Hepatol; 2009 Apr; 24(4):564-8. PubMed ID: 19378390 [Abstract] [Full Text] [Related]
16. Diagnostic value of MR-based texture analysis for the assessment of hepatic fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). Cannella R, Borhani AA, Tublin M, Behari J, Furlan A. Abdom Radiol (NY); 2019 May; 44(5):1816-1824. PubMed ID: 30788556 [Abstract] [Full Text] [Related]
17. Low Free Triiodothyronine Is Associated with Advanced Fibrosis in Patients at High Risk for Nonalcoholic Steatohepatitis. Manka P, Bechmann L, Best J, Sydor S, Claridge LC, Coombes JD, Canbay A, Moeller L, Gerken G, Wedemeyer H, Syn WK. Dig Dis Sci; 2019 Aug; 64(8):2351-2358. PubMed ID: 31155687 [Abstract] [Full Text] [Related]
18. Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet? Alkhouri N, Feldstein AE. Metabolism; 2016 Aug; 65(8):1087-95. PubMed ID: 26972222 [Abstract] [Full Text] [Related]
19. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity. Fracanzani AL, Petta S, Lombardi R, Pisano G, Russello M, Consonni D, Di Marco V, Cammà C, Mensi L, Dongiovanni P, Valenti L, Craxì A, Fargion S. Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682 [Abstract] [Full Text] [Related]
20. Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience. Yılmaz Y, Kanı HT, Demirtaş CÖ, Kaya E, Sapmaz AF, Qutranji L, Alkayyali T, Batun KD, Batman M, Toy B, Çiftaslan A. Turk J Gastroenterol; 2019 Oct; 30(10):892-898. PubMed ID: 31258138 [Abstract] [Full Text] [Related] Page: [Next] [New Search]